Technology
Health
Pharmaceutical

Lipocine

$1.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (0.56%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Lipocine and other stocks, options, ETFs, and crypto commission-free!

About LPCN

Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. Read More The company was founded in 2011 and is headquartered in Salt Lake City, UT.

Employees
10
Headquarters
Salt Lake City, Utah
Founded
2011
Market Cap
43.99M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
89.39K
High Today
$1.85
Low Today
$1.73
Open Price
$1.80
Volume
93.96K
52 Week High
$2.64
52 Week Low
$1.04

Collections

Technology
Health
Pharmaceutical
Research And Development
Therapy
2013 IPO
US
North America

LPCN Earnings

-$0.25
-$0.21
-$0.16
-$0.12
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.